FDA approves Vera Therapeutics' Trutakna for kidney disease

The FDA just gave the green light to Trutakna, a new drug from Vera Therapeutics designed to treat IgA nephropathy, a chronic kidney disease. This approval brings a new treatment option for patients grappling with this specific kidney condition.